相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data
Michael E. Cobble et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme
Odd Erik Johansen et al.
CARDIOVASCULAR DIABETOLOGY (2012)
FDA rejects novel diabetes drug over safety fears
Talha Khan Burki
LANCET (2012)
Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women
Tobias Pischon et al.
ATHEROSCLEROSIS (2011)
Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
Meimei Yin et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
Jose Luis Ferreiro et al.
CIRCULATION (2011)
Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
Zubair Shah et al.
CIRCULATION (2011)
Hypoglycaemia-induced myocardial infarction as a result of sulphonylurea misuse
B. T. Corley et al.
DIABETIC MEDICINE (2011)
Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications
Sonali Jindal et al.
HEMATOLOGY (2011)
Protective role of adiponectin on endothelial dysfunction induced by AGEs: A clinical and experimental approach
Serena Del Turco et al.
MICROVASCULAR RESEARCH (2011)
Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study
Henriette Thisted Horsdal et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Increased levels of platelet activation markers are positively associated with carotid wall thickness and other atherosclerotic risk factors in obese patients
Eva Csongradi et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Associations of inflammatory markers with coronary artery calcification: Results from the Multi-Ethnic Study of Atherosclerosis
Nancy Swords Jenny et al.
ATHEROSCLEROSIS (2010)
Vildagliptin A Review of its Use in Type 2 Diabetes Mellitus
Gillian M. Keating
DRUGS (2010)
Effects of One Year Treatment of Vildagliptin Added to Pioglitazone or Glimepiride in Poorly Controlled Type 2 Diabetic Patients
G. Derosa et al.
HORMONE AND METABOLIC RESEARCH (2010)
Severe Hypoglycemia and Risks of Vascular Events and Death.
Sophia Zoungas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Metalloproteases 2 and 9, Lp-PLA(2) and Lipoprotein Profile in Coronary Patients
Maria Luz Muzzio et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
Factors Contributing to Increased Platelet Reactivity in People With Diabetes
David J. Schneider
DIABETES CARE (2009)
Matrix metalloproteinases and inflammatory markers in coronary artery ectasia: their relationship to severity of coronary artery ectasia
Abdullah Dogan et al.
CORONARY ARTERY DISEASE (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease
S Blankenberg et al.
CIRCULATION (2003)
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins
U Rauch et al.
ATHEROSCLEROSIS (2000)